From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for patients with heart failure and a left ventricular ejection fraction (LVEF) ...

Altered exposures to eight factors contribute to increasing trends in ischemic heart disease (IHD) and stroke on a global scale.

SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Firearm injury-related emergency department visit rates increased from 2018 to 2020, then decreased through 2023.

Hospital and ICU admission rates within 30 days after COVID-19 infection were greater in patients with inborn errors of immunity (IEI).

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR).

Globally, antibiotic consumption increased 16.3% from 2016 to 2023 and is projected to continue increasing through 2030.

Overall, 13.9% of adults age 65 years and older met the federal physical activity guidelines for both aerobic and muscle-strengthening activities in 2022.

Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) or stroke in long-term care residents.

A large study suggests that, across the most populous US states, few physicians are disciplined for spreading medical misinformation.

Nearly half of participants in a weight loss program who initiated an antiobesity medication and who consumed alcohol at baseline reported decreases in their alcohol use.